EFFECT OF PROTAMINE ON HEPARIN-RELEASABLE TFPI ANTIGEN LEVELS IN NORMAL VOLUNTEERS

[1] Rapaport, The extrinsic pathway inhibitor: A regulator of tissue factor-dependent blood coagulation, Thromb Haemostasis, 66, pp. 6-15, (1991)

[2] Broze, Girard, Novotny, Regulaton of coagulation by a multivariant kunitz type inhibitor, Biochemistry, 29, (1990)

[3] Sandset, Abildgaard, Larsen, Heparin induces release of extrinsic coagulation pathway inhibitor (EPI), Thromb Res, 50, pp. 803-813, (1988)

[4] Nordfang, Kristensen, Valentin, Ostergaard, Wadt, The significance of TFPI in clotting assays — comparison and combination with other anticoagulants, Thromb Haemostas, 70, 3, pp. 448-453, (1993)

[5] Abildgaard, Lindahl, Sandset, Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood, Haemostasis, 21, pp. 2564-2570, (1991)

[6] Diness, Ostergaard, Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulfate in rats, Thromb Haemostasis, 56, 3, pp. 318-322, (1986)

[7] Gram, Mercker, Bruhn, Does protamine chloride neutralize low molecular weight heparin sufficiently?, Thromb Res, 52, pp. 353-359, (1988)

[8] Hubbard, Jennings, Neutralisation of heparan sulfate and low molecular weight heparin by protamine, Thromb Haemostasis, 53, 1, pp. 86-89, (1985)

[9] Harenberg, Siegele, Dempfle, Stehle, Heene, Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins, Thromb Haemostas, 70, 6, pp. 942-945, (1993)

[10] Holst, Lindbald, Bergqvist, Hedner, Garre, Nordfang, Ostergaard, Effect of protamine sulfate on tissue factor pathway inhibitor released by iv or sc standard heparin or low molecular weight heparin, Thromb Haemostas, 69, 6, (1993)

[1] Rapaport, The extrinsic pathway inhibitor: A regulator of tissue factor-dependent blood coagulation, Thromb Haemostasis, 66, pp. 6-15, (1991)

[2] Broze, Girard, Novotny, Regulaton of coagulation by a multivariant kunitz type inhibitor, Biochemistry, 29, (1990)

[3] Sandset, Abildgaard, Larsen, Heparin induces release of extrinsic coagulation pathway inhibitor (EPI), Thromb Res, 50, pp. 803-813, (1988)

[4] Nordfang, Kristensen, Valentin, Ostergaard, Wadt, The significance of TFPI in clotting assays — comparison and combination with other anticoagulants, Thromb Haemostas, 70, 3, pp. 448-453, (1993)

[5] Abildgaard, Lindahl, Sandset, Heparin requires both antithrombin and extrinsic pathway inhibitor for its anticoagulant effect in human blood, Haemostasis, 21, pp. 2564-2570, (1991)

[6] Diness, Ostergaard, Neutralization of a low molecular weight heparin (LHN-1) and conventional heparin by protamine sulfate in rats, Thromb Haemostasis, 56, 3, pp. 318-322, (1986)

[7] Gram, Mercker, Bruhn, Does protamine chloride neutralize low molecular weight heparin sufficiently?, Thromb Res, 52, pp. 353-359, (1988)

[8] Hubbard, Jennings, Neutralisation of heparan sulfate and low molecular weight heparin by protamine, Thromb Haemostasis, 53, 1, pp. 86-89, (1985)

[9] Harenberg, Siegele, Dempfle, Stehle, Heene, Protamine neutralization of the release of tissue factor pathway inhibitor activity by heparins, Thromb Haemostas, 70, 6, pp. 942-945, (1993)

[10] Holst, Lindbald, Bergqvist, Hedner, Garre, Nordfang, Ostergaard, Effect of protamine sulfate on tissue factor pathway inhibitor released by iv or sc standard heparin or low molecular weight heparin, Thromb Haemostas, 69, 6, (1993)